Cherry Thomas
No más puestos en curso
Historial de carrera de Cherry Thomas
Antiguos cargos conocidos de Cherry Thomas.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director Técnico/Científico/I+D | - | 01/03/2022 |
| JOUNCE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - | - |
| BEIGENE, LTD. | Director Técnico/Científico/I+D | - | - |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | - | - |
Formación de Cherry Thomas.
| University of California, Los Angeles | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Irvine | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Islas Caimán | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Cherry Thomas
- Experiencia
